TURNSTONE BIOLOGICS CORP. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.61 USD | -0.76% |
|
+0.38% | +2.55% |
| 13/05 | Turnstone Biologics Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 16/04 | Turnstone Biologics Corp. Announces Board Changes | CI |
Evolution of the average Target Price on Turnstone Biologics Corp.
Price target over the last 5 years
History of analyst recommendation changes
b93b1619064792f467c70fd9b97.uu44WbfcE0FmoCmqLGXyNna4vYwTE51HiVff0fJeyGQ.6NZXHfGmJSZRkWLedCieXxuB7uZxd8s1xCGOo54OilfVpggw-_FHDlTTEQ~9ea4b3df55afcb0f79b95e550e324e52
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
2.61
USD
Average target price
12.67
USD
Spread / Average Target
+385.31%
High Price Target
20
USD
Spread / Highest target
+666.28%
Low Price Target
6
USD
Spread / Lowest Target
+129.89%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Turnstone Biologics Corp.
| Piper Sandler | |
| BofA Securities |
EPS Revisions
- Stock Market
- Equities
- TSBX Stock
- Consensus Turnstone Biologics Corp.
